SERUM IRISIN LEVEL INCREASES THROUGHOUT THE GESTATIONAL PERIOD AND IT DOES NOT PLAY A ROLE IN DEVELOPMENT OF GESTATIONAL DIABETES MELLITUS


Creative Commons License

Saneak S., Aydin H., Sargin M. , Orcun A., Ozdemir A., Celik A., ...Daha Fazla

ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.13, ss.393-399, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 13 Konu: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4183/aeb.2017.393
  • Dergi Adı: ACTA ENDOCRINOLOGICA-BUCHAREST
  • Sayfa Sayıları: ss.393-399

Özet

Introduction. Irisin is a recently discovered novel adipomyokine that induces an increase in total body energy expenditure, improves insulin sensitivity and glucose tolerance. It has been shown that circulating levels of irisin are low in patients with obesity, diabetes mellitus and impaired glucose tolerance. However, the information about the level of circulating irisin in gestational diabetes mellitus (GDM) is controversial.